Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. trimmed its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 8.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,133 shares of the medical instruments supplier’s stock after selling 105 shares during the quarter. Securian Asset Management Inc.’s holdings in Mettler-Toledo International were worth $1,386,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Farther Finance Advisors LLC raised its stake in shares of Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 8 shares during the period. Huntington National Bank raised its stake in shares of Mettler-Toledo International by 20.0% during the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after buying an additional 9 shares during the period. Townsquare Capital LLC raised its stake in shares of Mettler-Toledo International by 2.0% during the 3rd quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock worth $693,000 after buying an additional 9 shares during the period. M3 Advisory Group LLC raised its stake in shares of Mettler-Toledo International by 5.8% during the 4th quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock worth $202,000 after buying an additional 9 shares during the period. Finally, Apollon Wealth Management LLC raised its stake in shares of Mettler-Toledo International by 2.5% during the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock worth $451,000 after buying an additional 9 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Wolfe Research assumed coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating for the company. Robert W. Baird increased their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Citigroup reduced their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Evercore ISI increased their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Finally, Wells Fargo & Company increased their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,380.50.

Mettler-Toledo International Stock Up 2.4 %

Shares of MTD opened at $1,231.32 on Friday. Mettler-Toledo International Inc. has a 52-week low of $1,142.91 and a 52-week high of $1,546.93. The company has a market capitalization of $25.75 billion, a PE ratio of 30.38, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15. The stock has a fifty day simple moving average of $1,295.03 and a two-hundred day simple moving average of $1,318.19.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, equities analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Christian Magloth sold 790 shares of the firm’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now directly owns 734 shares of the company’s stock, valued at $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.